BackSummit Therapeutics Overview

Summit Therapeutics Common Stock

Summit Therapeutics's common stock is $7.9M.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$7.93M
↑ 6.77% YoYΔ $503000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Summit Therapeutics Common Stock History

Loading

Summit Therapeutics vs. peers: Common Stock Comparison

Loading

Summit Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Summit Therapeutics (SMMT) FAQ

As of the most recent data (June 2026), SMMT shows a common stock of $7.9M. That compares with $7.4M in the prior-year period — up 6.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SMMT's common stock is now $7.9M (was $7.4M) — a 6.8% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Summit Therapeutics is outperforming or lagging.

Tracking SMMT's common stock over time shows whether Summit Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $7.9M That compares with $7.4M in the prior-year period — up 6.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Summit Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $7.9M) with ownership activity and broader fundamentals.